In SIT, patients in the OSAHS-PA group exhibited significantly higher levels of PAC and PRA at both at immediately after the start of the infusion and 4 h compared to patients in the OSAHS-no PA group. The gene discussed is S100A6; the disease is obstructive sleep apnea syndrome.